logo
logo

Femtech Startup Tuune Secures $4.6 Million In Financing To Launch In The U.S., Paving The Way For Personalized Birth Control

Oct 06, 2021•almost 4 years ago

Amount Raised

$4.6 Million

Round Type

seed

London

Description

Tuune, a femtech startup revolutionizing women’s health by offering individualized hormonal analysis and birth control, today announced the closing of a $4.6M fundraising round to launch in the U.S. market. The investment, led by venture capital firm Octopus Ventures, will support Tuune’s efforts to build a more individualized medical system that puts hormones first, transforming the future of healthcare for all women and people with cycles.

Company Information

Company

Tuune

Location

London, Ontario, Canada

About

Tuune is a personalized women’s healthcare company, re-inventing the way healthcare accesses the complexity of female hormones with a focus on individuality. Our mission is to make female hormones a pillar of modern holistic healthcare and bridge the gaps in understanding of conditions like PCOS; endometriosis; and cardiometabolic, mental, and bone health. Our first product educates and empowers women to choose the right birth control for their unique hormones and biology.